603392.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:00):

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally...

Stats
Dzisiejszy wolumen	4.51M
Średni wolumen	10.22M
Kapitalizacja rynkowa	86.30B
EPS	CNY-0.440 ( 2024-03-28 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	682.80
ATR14	CNY0.0270 (0.04%)

Wolumen Korelacja

Długi: 0.03 (neutral)

Krótki: 0.00 (neutral)

Signal:(48.063) Neutral

Beijing Wantai Biological Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Beijing Wantai Biological Korelacja - Waluta/Towar

0.36
( neutral )

0.12
( neutral )

0.00
( neutral )

0.34
( neutral )

-0.15
( neutral )

0.14
( neutral )

Beijing Wantai Biological Finanse

Annual	2023
Przychody:	CNY5.48B
Zysk brutto:	CNY4.50B (82.13 %)
EPS:	CNY0.990

FY	2023
Przychody:	CNY5.48B
Zysk brutto:	CNY4.50B (82.13 %)
EPS:	CNY0.990

FY	2022
Przychody:	CNY11.19B
Zysk brutto:	CNY10.01B (89.54 %)
EPS:	CNY3.79

FY	2021
Przychody:	CNY5.75B
Zysk brutto:	CNY4.93B (85.78 %)
EPS:	CNY3.46

Financial Reports:

No articles found.

Beijing Wantai Biological

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.